Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer therapies in HIV cure research
Thomas A. Rasmussen, Jenny L. Anderson, Fiona Wightman, et al.
Current Opinion in HIV and AIDS (2016) Vol. 12, Iss. 1, pp. 96-104
Open Access | Times Cited: 19

Showing 19 citing articles:

Immune checkpoint blockade in infectious diseases
Michelle Wykes, Sharon R. Lewin
Nature reviews. Immunology (2017) Vol. 18, Iss. 2, pp. 91-104
Open Access | Times Cited: 476
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Weiting Qin, Li-Peng Hu, Xueli Zhang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 331
HIV-hepatitis B virus coinfection
Kasha P. Singh, Megan Crane, Jennifer Audsley, et al.
AIDS (2017) Vol. 31, Iss. 15, pp. 2035-2052
Open Access | Times Cited: 206
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Rocío Granda‐Díaz, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 45
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal
Guoxin Wu, Michael D. Swanson, Aarthi Talla, et al.
JCI Insight (2017) Vol. 2, Iss. 16
Open Access | Times Cited: 67
Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice
Ronald Anderson, Bernardo L. Rapoport
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 41
Natural product-derived compounds in HIV suppression, remission, and eradication strategies
Raymond J. Andersen, Fidele Ntie‐Kang, Ian Tietjen
Antiviral Research (2018) Vol. 158, pp. 63-77
Closed Access | Times Cited: 35
HIV integration sites and implications for maintenance of the reservoir
Jori Symons, Paul Cameron, Sharon R. Lewin
Current Opinion in HIV and AIDS (2017) Vol. 13, Iss. 2, pp. 152-159
Open Access | Times Cited: 34
Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV
José M. Benito, Clara Restrepo, Jesús García‐Foncillas, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Ethical issues in HIV remission trials
Nir Eyal, Lisa Holtzman, Steven G. Deeks
Current Opinion in HIV and AIDS (2018) Vol. 13, Iss. 5, pp. 422-427
Open Access | Times Cited: 29
Nivolumab in HIV-related non-small-cell lung cancer
Marcus Hentrich, K. Schipek-Voigt, H. de Jager, et al.
Annals of Oncology (2017) Vol. 28, Iss. 11, pp. 2890-2890
Open Access | Times Cited: 27
Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9624-9624
Open Access | Times Cited: 7
Therapeutic HIV-1 vaccine
Nabila Seddiki, Yves Lévy
Current Opinion in HIV and AIDS (2018) Vol. 13, Iss. 2, pp. 119-127
Closed Access | Times Cited: 22
Single-molecule techniques to quantify and genetically characterise persistent HIV
Xiao Qian Wang, Sarah Palmer
Retrovirology (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Divergent SATB1 expression across human life span and tissue compartments
Simone Nüssing, Hui‐Fern Koay, Sneha Sant, et al.
Immunology and Cell Biology (2019) Vol. 97, Iss. 5, pp. 498-511
Open Access | Times Cited: 19
Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
Christina Gavegnano, Andrea Savarino, Taofeek Owanikoko, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 15
HIV and AIDS: An overview of the current issues, treatment and prevention
Elizabeth Crock
Nursing Standard (2017) Vol. 32, Iss. 15, pp. 51-63
Closed Access | Times Cited: 3
Clinical and scientific challenges in HIV-associated malignancies
Mark N. Polizzotto, Ronald T. Mitsuyasu
Current Opinion in HIV and AIDS (2016) Vol. 12, Iss. 1, pp. 1-5
Open Access | Times Cited: 2
Allogeneic stem cell transplantation alone is unlikely to provide the HIV-1 cure
Nathan W. Cummins, Andrew D. Badley
Future Virology (2018) Vol. 13, Iss. 5, pp. 307-308
Open Access
Page 1

Scroll to top